Northwestern Medicine investigators have identified a potential combined targeted therapy approach for treating glioblastoma, according to a recent study published in the journal Scientific Reports.
Reanna Williams, a first-year student in the Physician Assistant program and president of Feinberg’s PA class of 2022, is excited for the ample opportunities becoming a PA can offer her in the healthcare field.
A drug that demonstrated neuroprotective effect and slowed disease progression in animal models of Parkinson’s disease showed no symptomatic benefit in patients with the neurodegenerative disorder, according to results from a clinical trial led by Northwestern Medicine investigators.
Abbey Filicko, a third-year medical student, presented findings from her community-based participatory research project in partnership with Chicago Public Schools at this year’s American Public Health Association (APHA) virtual annual meeting.
A multi-disciplinary team of investigators led by Northwestern scientists have developed a novel wireless device that can constantly monitor pressure and temperature between the patient’s skin and prosthesis, improving overall comfort and wellbeing.
Vitrectomy surgery and intravitreal injections showed similar effectiveness in improving overall vision for patients with advanced diabetic retinopathy, according to results from a clinical trial published in JAMA.
Overall mortality for patients hospitalized for COVID-19 in the U.S. during the first half of 2020 was 18.4 percent, with more than half of all deaths occurring in Black and Hispanic patients, according to findings published in the journal Circulation.
The third annual Northwestern Women in Medicine conference kicked off on December 17, and will feature monthly virtual lectures aimed to empower women in medicine to thrive in a virtual world.
A new wellness curriculum program developed by Northwestern Medicine faculty and residents may help decrease burnout among trainees, according to a recent study.
A team led by Northwestern Medicine investigators has identified a novel molecular target that may improve the efficacy of current treatments for triple-negative breast cancer.